专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20110160426A1 HYDROLYTICALLY DECOMPOSABLE IONIC COPOLYMERS 有权
标题翻译：水解非离子型离子共聚物
公开(公告)号：US20110160426A1
公开(公告)日：2011-06-30
申请号：US12937631
申请日：2009-04-09
申请人： Andreas Greiner , Seema Agarwal , Thomas Kissel , Liqun Ren
发明人： Andreas Greiner , Seema Agarwal , Thomas Kissel , Liqun Ren
IPC分类号： C08G63/685 , C08G63/68 , C08G75/24 , C08G63/692 , C09J167/00 , B82Y40/00
CPC分类号： C08L101/16 , C08F8/44 , C08F216/38 , C08F220/14 , C08F220/34 , C08F2800/10 , C08F120/34
摘要： The invention at hand provides hydrolytically degradable ionic copolymers. These ionic copolymerizates are composed of one cyclic ketene acetal A, one anionic or cationic methacrylic acid derivative B, selected from 2-methyl-methacrylate, [2-(2-methyl-1-methylene-allyloxy)]ethanesulfonate, [2-(2-methyl-1-methylene-allyloxy)ethyl]phosphonate or a quaternary amine of the N,N-dimethylaminoethylmethacrylic acid (DMAEMA) and, optionally, a neutral methacrylic acid derivative C.The hydrolytically degradable anionic copolymers according to the present invention are produced by polymerizing the components A, B and C in the presence of a radical initiator under inert gas atmosphere and subsequent purification.All copolymers according to the present invention are hydrolytically degradable. Copolymers comprising a maximum of 40 mol-% of ester groups in the backbone are additionally biodegradable, wherein in the case of cationic copolymers a maximum of 20 mol-% of quaternized DMAEMA is allowed to be available.Cationic copolymers comprising at least 50 mol-% of the component B are antimicrobial.Both anionic as well as cationic copolymers are suitable for producing nanoparticles. Cationic copolymers are suitable for being used as superhydrophobic materials as well as adhesives. Anionic copolymers are suitable for biodegradable thermoplastic elastomers and for biodegradable ionomers.
摘要翻译：本发明提供了可水解降解的离子共聚物。这些离子共聚物由选自2-甲基 - 甲基丙烯酸酯，[2-（2-甲基-1-亚甲基 - 烯丙氧基）]乙磺酸酯，[2-（2-甲基-1-亚甲基 - 烯丙氧基）]乙磺酸的一种环状烯酮缩醛A，一种阴离子或阳离子甲基丙烯酸衍生物B组成， 2-甲基-1-亚甲基 - 烯丙氧基）乙基]膦酸酯或N，N-二甲基氨基乙基甲基丙烯酸（DMAEMA）和任选的中性甲基丙烯酸衍生物C的季胺。根据本发明的可水解降解的阴离子共聚物是通过在惰性气体气氛下在自由基引发剂的存在下将组分A，B和C聚合并随后纯化而制备。根据本发明的所有共聚物都是可水解降解的。在主链中包含最多40mol％的酯基的共聚物另外是可生物降解的，其中在阳离子共聚物的情况下，允许最多20mol％的季铵化DMAEMA可用。包含至少50mol％的组分B的阳离子共聚物是抗微生物剂。阴离子和阳离子共聚物都适用于生产纳米颗粒。阳离子共聚物适合用作超疏水材料以及粘合剂。阴离子共聚物适用于可生物降解的热塑性弹性体和可生物降解的离聚物。

2. 发明授权

US09068065B2 Hydrolytically decomposable ionic copolymers 有权
标题翻译：水解可分解的离子共聚物
公开(公告)号：US09068065B2
公开(公告)日：2015-06-30
申请号：US12937631
申请日：2009-04-09
申请人： Andreas Greiner , Seema Agarwal , Thomas Kissel , Liqun Ren
发明人： Andreas Greiner , Seema Agarwal , Thomas Kissel , Liqun Ren
IPC分类号： C08F20/06 , C08L101/16 , C08F8/44 , C08F220/34 , C08F216/38 , C08F220/14
CPC分类号： C08L101/16 , C08F8/44 , C08F216/38 , C08F220/14 , C08F220/34 , C08F2800/10 , C08F120/34
摘要： The invention at hand provides hydrolytically degradable ionic copolymers. These ionic copolymerizates are composed of one cyclic ketene acetal A, one anionic or cationic methacrylic acid derivative B, selected from 2-methyl-methacrylate, [2-(2-methyl-1-methylene-allyloxy)]ethanesulfonate, [2-(2-methyl-1-methylene-allyloxy)ethyl]phosphonate or a quaternary amine of the N,N-dimethylaminoethylmethacrylic acid (DMAEMA) and, optionally, a neutral methacrylic acid derivative C.The hydrolytically degradable anionic copolymers according to the present invention are produced by polymerizing the components A, B and C in the presence of a radical initiator under inert gas atmosphere and subsequent purification.All copolymers according to the present invention are hydrolytically degradable. Copolymers comprising a maximum of 40 mol-% of ester groups in the backbone are additionally biodegradable, wherein in the case of cationic copolymers a maximum of 20 mol-% of quaternized DMAEMA is allowed to be available.Cationic copolymers comprising at least 50 mol-% of the component B are antimicrobial.Both anionic as well as cationic copolymers are suitable for producing nanoparticles. Cationic copolymers are suitable for being used as superhydrophobic materials as well as adhesives. Anionic copolymers are suitable for biodegradable thermoplastic elastomers and for biodegradable ionomers.
摘要翻译：本发明提供了可水解降解的离子共聚物。这些离子共聚物由选自2-甲基 - 甲基丙烯酸酯，[2-（2-甲基-1-亚甲基 - 烯丙氧基）]乙磺酸酯，[2-（2-甲基-1-亚甲基 - 烯丙氧基）]乙磺酸的一种环状烯酮缩醛A，一种阴离子或阳离子甲基丙烯酸衍生物B组成， 2-甲基-1-亚甲基 - 烯丙氧基）乙基]膦酸酯或N，N-二甲基氨基乙基甲基丙烯酸（DMAEMA）和任选的中性甲基丙烯酸衍生物C的季胺。根据本发明的可水解降解的阴离子共聚物是通过在惰性气体气氛下在自由基引发剂的存在下将组分A，B和C聚合并随后纯化而制备。根据本发明的所有共聚物都是可水解降解的。在主链中包含最多40mol％的酯基的共聚物另外是可生物降解的，其中在阳离子共聚物的情况下，允许最多20mol％的季铵化DMAEMA可用。包含至少50mol％的组分B的阳离子共聚物是抗微生物剂。阴离子和阳离子共聚物都适用于生产纳米颗粒。阳离子共聚物适合用作超疏水材料以及粘合剂。阴离子共聚物适用于可生物降解的热塑性弹性体和可生物降解的离聚物。

3. 发明申请

US20120148493A1 Composite Materials Loaded with Therapeutic and Diagnostic Agents Comprising Polymer Nanoparticles and Polymer Fibers 审中-公开
标题翻译：由聚合物纳米颗粒和聚合物纤维组成的包含治疗和诊断剂的复合材料
公开(公告)号：US20120148493A1
公开(公告)日：2012-06-14
申请号：US13256872
申请日：2010-03-16
申请人： Thomas Schmehl , Juliane Nguyen , Moritz Beck-Broichsitter , Tobias Gessler , Thomas Kissel , Marcel Thieme
发明人： Thomas Schmehl , Juliane Nguyen , Moritz Beck-Broichsitter , Tobias Gessler , Thomas Kissel , Marcel Thieme
IPC分类号： A61K9/70 , A61P9/00 , A61P11/00 , A61P11/06 , A61P35/00 , A61P17/00 , A61P17/02 , D01D5/00 , A61K49/00 , A61P3/00 , B82Y5/00
CPC分类号： A61K9/5153 , A61K9/70
摘要： The invention relates to composite materials comprising polymer nanofibers and polymer nanoparticles, wherein at least one of the two polymer materials is loaded with a substance selected from therapeutic and diagnostic agents. Fibers and nanoparticles can comprise identical or different polymers; the polymer materials are, however, biocompatible in every case. Therapeutic and diagnostic agents can be hydrophilic or lipophilic and the two polymer materials likewise. The at least one polymer material and the substance with which said material is loaded are either both hydrophilic or both lipophilic. The polymer nanoparticles of the composite materials have a diameter of 10 nm to 600 nm. The polymer fibers have diameters of 10 nm to 50 μm and lengths of 1 μm to several meters. The invention further relates to a method for producing said composite materials. Polymer nanoparticles can be produced in different ways, such as through controlled precipitation of a polymer solution that optionally comprises a loading substance. The nanoparticles are then mixed with another polymer and a loading substance as applicable, depending on whether particles, fibers or both are to be loaded with substance. The processing of this solution into composites comprising polymer fibers polymer nanoparticles can occur by means of electrospinning, melt spinning, extruding or template process. Composite materials according to the invention are suitable for the production of pharmaceuticals that release therapeutically or diagnostically effective substances slowly and in a controlled manner.
摘要翻译：本发明涉及包含聚合物纳米纤维和聚合物纳米颗粒的复合材料，其中两种聚合物材料中的至少一种负载有选自治疗剂和诊断剂的物质。纤维和纳米颗粒可以包含相同或不同的聚合物; 然而，聚合物材料在每种情况下都是生物相容的。治疗和诊断剂可以是亲水的或亲脂的，并且两种聚合物材料同样。所述至少一种聚合物材料和所述材料被加载的物质既是亲水的，也是亲油的。复合材料的聚合物纳米颗粒具有10nm至600nm的直径。聚合物纤维的直径为10nm〜50μm，长度为1〜数米。本发明还涉及一种生产所述复合材料的方法。聚合物纳米颗粒可以以不同的方式制备，例如通过可选地包含负载物质的聚合物溶液的可控沉淀。然后将纳米颗粒与另一种聚合物和负载物质混合，这取决于颗粒，纤维或两者是否被装载物质。将该溶液加工成包含聚合物纤维聚合物纳米颗粒的复合材料可以通过静电纺丝，熔融纺丝，挤出或模板方法进行。根据本发明的复合材料适用于缓慢地并以受控方式释放治疗或诊断有效物质的药物。

4. 发明申请

US20050118271A1 Polytartrate composition 审中-公开
标题翻译：聚酒石酸成分
公开(公告)号：US20050118271A1
公开(公告)日：2005-06-02
申请号：US10501284
申请日：2003-01-15
申请人： Gesine Schliecker , Carsten Schmidt , Stefan Fuchs , Thomas Kissel
发明人： Gesine Schliecker , Carsten Schmidt , Stefan Fuchs , Thomas Kissel
IPC分类号： A61K9/20 , A61K9/22 , A61K38/09 , A61K38/24 , A61K45/00 , A61K47/34 , A61P5/04 , A61K39/395 , A61K9/14 , A61K39/00
CPC分类号： A61K9/2031 , A61K38/09
摘要： The invention provides a polytartrate composition for pulsatile release of a pharmaceutically active material that is in the form of a compressed tablet, and a process for preparing such a composition.
摘要翻译：本发明提供了一种用于脉冲释放呈压片剂形式的药物活性物质的酒石酸盐组合物及其制备方法。

5. 发明授权

US5593686A Pharmaceutical compositions 失效
标题翻译：药物组合物
公开(公告)号：US5593686A
公开(公告)日：1997-01-14
申请号：US314167
申请日：1994-09-28
申请人： Thomas Kissel , Henriette Schrank , Hans-Rainer Hoffmann
发明人： Thomas Kissel , Henriette Schrank , Hans-Rainer Hoffmann
IPC分类号： A61K9/70 , A61K31/40 , A61F13/02
CPC分类号： A61K9/7061 , A61K31/40 , A61K9/7084
摘要： The present invention provides a pharmaceutical composition for the transdermal systemic administration of an active agent characterized in that the active agent is bopindolol or methysergide. Also the present invention provides a pharmaceutical composition for the transdermal systemic administration of a pharmacologically active agent characterized in that it contains bopindolol, tizanidine, clemastine, ketotifen or methysergide as active agent in a reservoir comprising a hydrophilic polymer. Furthermore a pharmaceutical composition for the transdermal systemic administration of pharmacologically active agents characterized in that the pharmacologically active agent is in a reservoir comprising a polyacrylate polymer containing cationic ester groups.
摘要翻译：本发明提供了一种用于经皮全身给药活性剂的药物组合物，其特征在于活性剂是苯吲哚洛尔或甲基麦角苷。本发明还提供了一种药物组合物，其用于药理学活性剂的经皮系统性给药，其特征在于在包含亲水性聚合物的储库中含有苯妥萘洛，替扎尼定，克立马斯酮，酮替芬或甲基麦角苷作为活性剂。此外，用于经皮系统施用药理活性剂的药物组合物，其特征在于药理活性剂在包含含有阳离子酯基的聚丙烯酸酯聚合物的储库中。

6. 发明申请

US20110305742A1 PHARMACEUTICAL COMPOSITIONS 审中-公开
标题翻译：药物组合物
公开(公告)号：US20110305742A1
公开(公告)日：2011-12-15
申请号：US13090788
申请日：2011-04-20
申请人： Michael Ausborn , Thomas Kissel
发明人： Michael Ausborn , Thomas Kissel
IPC分类号： A61K9/00 , A61P9/00
CPC分类号： A61L31/16 , A61L29/085 , A61L29/16 , A61L31/10 , A61L2300/416 , A61L2300/604 , C08L69/00
摘要： A device implantable into a human or animal body comprising a biodegradable polymer which comprises ethylene carbonate units of the formula A -(—C(O)—O—CH2—CH2—O—)- A having an ethylene carbonate content of 70 to 100 Mol %, an intrinsic viscosity of 0.4 to 4.0 dl/g measured in chloroform at 20° C. at a concentration of 1 g/dl and a glass transition temperature of from 5 to 50° C., degradable by surface erosion which is governed by a non-hydrolytic mechanism.
摘要翻译：一种可植入人或动物体内的装置，其包含可生物降解的聚合物，其包含具有70-100的碳酸亚乙酯含量的式A-（-C（O）-O-CH 2 -CH 2 -O - ） - 的亚碳酸酯单元分子％，特性粘度为0.4〜4.0dl / g，在氯仿中在20℃下以1g / dl的浓度和5〜50℃的玻璃化转变温度测定，可通过表面侵蚀进行降解通过非水解机理。

7. 发明申请

US20100239524A1 MICROPARTICLES PREPARED USING AN IONIC LIQUID 审中-公开
标题翻译：使用离子液体制备的微波炉
公开(公告)号：US20100239524A1
公开(公告)日：2010-09-23
申请号：US12789588
申请日：2010-05-28
申请人： Michael Ausborn , Thomas Kissel , Ernst Küsters
发明人： Michael Ausborn , Thomas Kissel , Ernst Küsters
IPC分类号： A61K38/22
CPC分类号： A61K9/1694 , A61K9/1647
摘要： Microparticles comprising at least one active agent embedded within a biocompatible, biodegradable polymeric matrix, wherein said microparticles are prepared with an ionic liquid.
摘要翻译：包含至少一种包含在生物相容的可生物降解的聚合物基质内的活性剂的微粒，其中所述微粒用离子液体制备。

8. 发明授权

US5929196A Polyesters of a polyhydroxycarboxylic acid and a polyol having a substituent with electrolyte properties 失效
标题翻译：聚羟基羧酸的聚酯和具有电解质性质的取代基的多元醇
公开(公告)号：US5929196A
公开(公告)日：1999-07-27
申请号：US817860
申请日：1997-04-24
申请人： Thomas Kissel , Youxin Li
发明人： Thomas Kissel , Youxin Li
IPC分类号： A61K9/16 , A61K9/22 , C08G63/60 , C08G63/68 , C08G63/00
CPC分类号： C08G63/68 , A61K9/1647 , C08G63/60
摘要： The invention relates to new polyesters of a polyol containing substituents with electrolyte properties with polymeric hydroxycarboxylic esters, their method of preparation and their use. The polyesters are particularly suitable for use in the preparation of sustained-release drugs.
摘要翻译： PCT No.PCT / EP95 / 00655 Sec。 371日期1997年04月24日 102（e）日期1997年4月24日PCT提交1995年2月23日PCT公布。公开号WO95 / 23175 PCT 日期1995年8月31日本发明涉及含聚合羟基羧酸酯的具有电解质性质的取代基的多元醇的新型聚酯，其制备方法及其应用。聚酯特别适用于缓释药物的制备。

9. 发明授权

US5639480A Sustained release formulations of water soluble peptides 失效
标题翻译：水溶性肽的缓释制剂
公开(公告)号：US5639480A
公开(公告)日：1997-06-17
申请号：US470072
申请日：1995-06-06
申请人： David Bodmer , Jones W. Fong , Thomas Kissel , Hawkins V. Maulding , Oskar Nagele , Jane E. Pearson
发明人： David Bodmer , Jones W. Fong , Thomas Kissel , Hawkins V. Maulding , Oskar Nagele , Jane E. Pearson
IPC分类号： A61K9/16 , A61K9/50 , A61K38/31 , A61K9/14
CPC分类号： A61K9/1647 , A61K38/31 , A61K9/5031
摘要： The invention discloses microparticles comprising a polypeptide, preferably somatostatin or an analog or derivative thereof, more preferably octreotide, in a polymeric matrix, preferably poly(lactide-co-glycolide)glucose. The invention also discloses sustained release formulations containing said microparticles and the use of said formulations in treating acromegaly and breast cancer.
摘要翻译：本发明公开了在聚合物基质，优选聚（丙交酯 - 共 - 乙交酯）葡萄糖中包含多肽，优选生长抑素或其类似物或衍生物，更优选奥曲肽的微粒。本发明还公开了含有所述微粒的缓释制剂和所述制剂在治疗肢端肥大症和乳腺癌中的用途。

10. 发明申请

US20100254939A1 GRAFT COPOLYMERS AS DRUG DELIVERY SYSTEMS 有权
标题翻译： GRAFT共聚物作为药物递送系统
公开(公告)号：US20100254939A1
公开(公告)日：2010-10-07
申请号：US12677602
申请日：2008-09-08
申请人： Thomas Kissel , Xiaoying Wang
发明人： Thomas Kissel , Xiaoying Wang
IPC分类号： A61K38/20 , A61P11/00 , A61K38/21 , A61K38/19 , A61K38/09 , A61K38/22 , A61K38/18 , A61K38/28 , A61K38/31 , A61K38/26 , A61K38/23 , A61K38/48 , A61K38/12 , A61K31/137 , A61K31/4704 , A61K31/167 , A61K31/439 , A61K31/46 , C08F273/00 , B32B27/00 , C08F263/04
CPC分类号： C08F263/04 , A61K9/006 , A61K9/0073 , A61K9/5138 , C08F273/00 , C08G63/08 , C08G81/027 , C08J3/14 , C08J2367/04
摘要： The present invention relates to graft copolymers of polyvinyl sulfonic-co-vinyl alcohol)-g-poly(lactide-co-glycolide) (P(VS-VA)-g-PLGA) with negatively charged electrolyte properties, their method of preparation and their use. These negatively charged graft copolymers are suitable for effective loading and sustained-release of especially positively charged drugs, proteins and peptides, and drug-loaded particles from these grafted co-polymers are especially useful as parenteral or mucosal drug delivery systems for pharmaceutical applications.
摘要翻译：本发明涉及聚乙烯基磺酸 - 共 - 乙烯醇）-g-聚（丙交酯 - 共 - 乙交酯）（P（VS-VA）-g-PLGA）与带负电荷的电解质的接枝共聚物，它们的制备方法和他们的使用。这些带负电荷的接枝共聚物适用于特别是带正电荷的药物，蛋白质和肽的有效负载和持续释放，并且来自这些接枝的共聚物的药物负载的颗粒特别可用作药物应用的肠胃外或粘膜药物递送系统。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式